Summary
The neurologic symptoms accompanying severe liver disease have been termed hepatic coma. This syndrome is characterized by personality changes, inappropriate behavior, stupor, and eventually coma. The peculiar flapping tremor is the most characteristic physical finding. Abnormalities of the electroencephalogram have been correlated with the depth of coma. The neuropathologic changes accompanying hepatic coma are limited to a diffuse protoplasmic astrocytosis.
The most frequent biochemical abnormality is an elevation of the blood ammonia. This results from the breakdown of nitrogenous products in the bowel which reach the brain in toxic quantities as the result of portal venous collateral circulation around the liver and/or as the result of defective liver function.
Treatment is directed toward improving liver function and removing the toxic breakdown products of gastrointestinal hemorrhage from the bowel. Administration of sodium glutamate has been used with variable results. Similar observations have been reported concerning the value of adrenal steroid therapy and administration of oral antibiotics.
Similar content being viewed by others
References
Adams, R. D., andFoley, J. M. The neurological disorder associated with liver disease.Proc. A. Res. Nerv. & Ment. Dis. 32:198, 1953.
Alexander, J. W., andPorter, C. E. The treatment of a patient in hepatic coma with intravenous sodium glutamate and ACTH.Gastroenterology 26:926, 1953.
Alexander, R. W., Berman, E., andBalfour, D. C., Jr. Relationship of glutamic acid and blood ammonium to hepatic coma.Gastroenterology 29:711, 1955.
Amatuzio, D. S., andNesbitt, S. A study of pyruvic acid in the blood and spinal fluid of patients with liver disease with and without hepatic coma.J. Clin. Invest. 29:1486, 1950.
Amatuzio, D. S.,et al. A study of serum electrolytes (Na, K, Ca, P) in patients with severely decompensated portal cirrhosis of the liver.J. Lab. & Clin. Med. 39:26, 1952.
Amatuzio, D. S., Weber, L. J., andNesbitt, S. Bilirubin and protein in the cerebrospinal fluid of jaundiced patients with severe liver disease with and without coma.J. Lab. & Clin. Med. 41:615, 1953.
Benhamou, J. P., Hartmann, L., andFauvert, R. Transitory hepatic coma: I. Clinical study.Presse méd. 63:1451, 1955.
Bessman, S. P. “Ammonia Metabolism in Animals.” InMcElroy, W. D., andGlass, B. (Eds.):Inorganic Nitrogen Metabolism. Baltimore, Johns Hopkins Press, 1956.
Bessman, S. P. The role of ammonia in clinical syndromes.Ann. Int. Med. 44:1037, 1956.
Bessman, S. P., andBessman, A. N. The cerebral and peripheral uptake of ammonia in liver disease with an hypothesis for the mechanism of hepatic coma.J. Clin. Invest. 34:622, 1955.
Bessman, S. P., andBradley, J. M. Uptake of ammonia by muscle.New England J. Med. 253:1143, 1955.
Bessman, S. P., Fazekas, J. F., andBessman, A. N. Uptake of ammonia by the brain in hepatic coma.Proc. Soc. Exper. Biol. & Med. 85:66, 1954.
Bickford, R. G., andButt, H. R. Hepatic coma: The electroencephalographie pattern.J. Clin. Invest. 34:790, 1955.
Butt, H. R. Panel discussion: The clinical and biochemical features of hepatic insufficiency.Gastroenterology 25:471, 1953.
Butt, H. R., andMason, H. L. Fetor hepaticus: Its clinical significance and attempts at chemical isolation.Gastroenterology 26:829, 1954.
Carfagno, S. C.,et al. Hepatic coma: A clinical, laboratory and pathological study.New England J. Med. 249:303, 1953.
Chalmers, T. C.,et al. The effects of intravenous sodium glutamate on blood “ammonia,” ketoacids and amino acids in patients with hepatic coma.J. Clin. Invest. 34:926, 1955.
Davidson, C. S. Cirrhosis of the liver.Am. J. Med. 16:863, 1954.
Davidson, C. S. Cirrhosis of the liver treated with prolonged sodium restrictions.J.A.M.A. 159:1257, 1955.
Davidson, C. S. “Hepatic Coma.” InDock, W., andSnapper, I. (Eds.):Advances in Internal Medicine. Chicago, Yr. Bk. Pub. 1955, Vol. VII, pp. 33–63.
Davidson, C. S. “Hepatic Coma.” InSchiff, L. (Ed.):Diseases of the Liver. Philadelphia, Lippincott, 1956.
Ducci, H. Cortisone in hepatitis: Recovery in five comatose cases.Merck Rep. 62:213, 1953.
Eberling, W. C.,et al. Management of patients with portal hypertension undergoing venous-shunt surgery.New England J. Med. 254:141, 1956.
Evans, A. S., Spring, H., andNelson, R. S. Adrenal hormone therapy in viral hepatitis: III. The effect of ACTH and cortisone in severe and fulminant cases.Ann. Int. Med. 38:1148, 1953.
Farquhar, J. D.,et al. Studies on the use of Aureomycin in hepatic disease: III. A note on Aureomycin therapy in hepatic coma.Am. J. M. Sc. 220:166, 1950.
Foley, J. M., Watson, C. W., andAdams, R. D. Significance of the electroencephalographic changes in hepatic coma.Tr. Am. Neurol. A. 75:161, 1950.
Foulk, W. T.,et al. Hepatic coma: A clinical and pathologic study.Gastroenterology 29:171, 1955.
Frerichs, F. T. A Clinical Treatise on Diseases of the Liver. Translated by C. Murchison. London, New Sydenham Society, 1860, Vol. I, p. 241.
Fuld, H. Uber die diagnostische Verwertbarkeit von Ammoniakbestimmungen im Blut.Klin. Wchnschr. 12:1364, 1933.
Gabuzda, G. J., Jr., Traeger, H. S., andDavidson, C. S. Effects of sodium chloride administration and restriction and of abdominal paracentesis on electrolyte and water balance.J. Clin. Invest. 33:780, 1954.
Havens, L. L., andChild, C. G. Recurrent psychosis associated with liver disease and elevated blood ammonia.New England J. Med. 252:756, 1955.
Jones, C. M. The role of experimental medicine in our understanding of the function of the liver in health and disease.Proc. Staff Meet. Mayo Clin. 27:553, 1952.
Kirk, E. Amino-acid and ammonia metabolism in liver diseases.Acta med. scand. (Suppl.)77:1, 1936.
Karl, M. M.,et al. Liver coma, with particular reference to management.Arch. Int. Med. 91:159, 1953.
McDermott, W. V., Jr., andAdams, R. D. Episodic stupor associated with an Eck fistula in the human with particular reference to the metabolism of ammonia.J. Clin. Invest. 33:1, 1954.
McDermott, W. V., Adams, R. D., andRiddell, A. G. Ammonia levels in blood and cerebrospinal fluid.Proc. Soc. Exper. Biol. & Med. 88:380, 1955.
McDermott, W. V., Jr., Warsham, J., andRiddell, A. G. Treatment of “hepatic coma” withl-glutamic acid.New England J. Med. 253:1093, 1955.
Murphy, T. L.,et al. Hepatic coma: Clinical and laboratory observations on fatty patients.New England J. Med. 239:605, 1948.
Nesbitt, S. Excretion of coproporphyrin in hepatic disease: III. Urinary excretion of coproporphyrin in hepatic insufficiency during episodes characterized by neurologic manifestations.Arch. Int. Med. 71:62, 1953.
Phear, E., Sherlock, S., andSummerskill, W. H. J. Blood ammonium levels in liver disease and hepatic coma.Lancet 268:836, 1955.
Phillips, G. B.,et al. The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances.New England J. Med. 247:239, 1951.
Riddell, A. G., Kopple, P. N., andMcDermott, W. V., Jr. Etiology of “meat intoxication” in Eck fistula dog.Surgery 36:675, 1954.
Sborov, V. M.,et al. The clinical usefulness of ACTH and cortisone in liver disease.Gastroenterolgy 28:745, 1955.
Schwartz, R.,et al. Dietary protein in the genesis of hepatic coma.New England J. Med. 251:685, 1954.
Seegmiller, J. E., Schwartz, R., andDavidson, C. S. The plasma “ammonia” and glutamine content in patients with hepatic coma.J. Clin. Invest. 33:984, 1954.
Seligson, D., McCormick, G. J., andSborov, V. Blood ketoglutarate and pyruvate in liver disease.J. Clin. Invest. 31:661, 1952.
Sessions, J. T., Jr.,et al. The effect of barbiturates in patients with liver disease.J. Clin. Invest. 33:1116, 1954.
Sherlock, S. Diseases of the Liver and Biliary System. Springfield, Ill., Thomas, 1955, pp. 96–110.
Sherlock, S. Treatment of hepatic coma.Gastroenterologia 85:241, 1956.
Sherlock, S.,et al. Portal-systemic encephalopathy: Neurological complications of liver disease.Lancet 2:453, 1954.
Snell, A. M., andButt, H. R. Hepatic coma: Observations bearing on its nature and treatment.Tr. A. Am. Physicians 56:321, 1941.
Traeger, H. S.,et al. Blood “ammonia” concentration in liver disease and liver coma.Metabolism 3:99, 1954.
Waelsch, H.,et al. Glutamic acid antimetabolites: The sulfoxide derived from methionine.J. Biol. Chem. 166:273, 1946.
Walshe, J. M. Observation on the symptomatology and pathogenesis of hepatic coma.Quart. J. Med. 20:421, 1951.
Walshe, J. M. Glutamic acid in hepatic coma.Lancet 268:1235, 1955.
Walshe, J. M. The effect of glutamic acid on the coma of hepatic failure.Lancet 1:1075, 1953.
Webster, L. T., Jr. The production of impending hepatic coma in alcoholics with cirrhosis by a carbonic anhydrase inhibitor (Diamox).J. Clin. Invest. 34:969, 1955.
Webster, L. T., Jr., andDavidson, C. S. Hepatic coma: Effect of sodium glutamate.J. Clin. Invest. 33:971, 1954.
Welch, C. S.,et al. Treatment of bleeding from portal hypertension in patients with cirrhosis of the liver.New England J. Med. 254:493–502, 1956.
Weil-Malherbe, H. Studies on brain metabolism: I. The metabolism of glutamic acid in brain.Biochem. J. 30:665, 1936.
White, L. P.,et al. Ammonium tolerance in liver disease: Observations based on catheterization of the hepatic veins.J. Clin. Invest. 34:158, 1955.
Wu, C., Bollman, J. L., andButt, H. R. Changes in free amino acids in the plasma during hepatic coma.J. Clin. Invest. 34:845, 1955.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clinton Texter, E., Borden, C.W. Hepatic coma. Digest Dis Sci 3, 159–177 (1958). https://doi.org/10.1007/BF02232388
Issue Date:
DOI: https://doi.org/10.1007/BF02232388